Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
17.04.23 | Notice - Termination of coverage - Termination of coverage | 286 | Edison Investment Research | Edison Investment Research is terminating coverage on Arovella Therapeutics (SUD), YouGov (YOU), CVC Income & Growth (CCPG), Mynaric (M0Y), Newmont Corporation (NEW) and Antisense Therapeutics (ANP).... ► Artikel lesen | |
17.04.23 | RTW Venture Fund - Acquisition of largest holding at healthy premium | 354 | Edison Investment Research | On Sunday 16 April 2023, US major pharma company Merck (NYSE: MRK) announced that, through a subsidiary, it had entered into a definitive agreement to acquire Prometheus Biosciences (NASDAQ: RXDX) for... ► Artikel lesen | |
17.04.23 | KEFI Gold and Copper - New timings | 470 | Edison Investment Research | Notwithstanding the trials and tribulations that it has had to deal with in Ethiopia in recent years, KEFI believes that it is finally nearing the end of its approvals odyssey. Being first mover and... ► Artikel lesen | |
17.04.23 | Regional REIT - Covered dividend with a 12% yield | 289 | Edison Investment Research | Regional REIT (RGL) delivered a good income performance in FY22, led by strong leasing (well above pre-pandemic levels) and continued strong rent collection. DPS of 6.6p was fully covered and we forecast... ► Artikel lesen | |
17.04.23 | Ergomed - Solid FY22 marked by broad-based growth | 624 | Edison Investment Research | Ergomed reported FY22 results broadly in line with our expectations. Group revenues grew 22.5% y-o-y to £145.3m, underpinned by sustained demand for both the CRO and PV segments and supported by the... ► Artikel lesen | |
17.04.23 | JDC Group - Strong results in a difficult market | 472 | Edison Investment Research | JDC Group (JDC) reported FY22 results that were in line with the preliminary results published on 9 March. After slower than expected growth in H222, JDC expects 2023 revenue growth to accelerate again... ► Artikel lesen | |
17.04.23 | Treatt - Strong revenue growth, profit in line | 345 | Edison Investment Research | After the usual slower start to the year, Treatt has had a strong Q2; H123 sales growth was 8.5% at constant currency. Momentum is expected to continue into H2, with current sales growth mainly skewed... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 357 |
EVOTEC | 323 |
TUI | 239 |
NVIDIA | 195 |
DEUTSCHE BANK | 191 |
BAYER | 174 |
PLUG POWER | 157 |
RHEINMETALL | 148 |
NEL | 146 |
SIEMENS ENERGY | 131 |
COMMERZBANK | 117 |
BARRICK GOLD | 116 |
TESLA | 112 |
BASF | 111 |
VOLKSWAGEN | 109 |
RWE | 102 |
DEUTSCHE LUFTHANSA | 98 |
BYD | 96 |
ALLIANZ | 92 |
DEUTSCHE TELEKOM | 91 |
MERCEDES-BENZ | 90 |
RENK GROUP | 88 |
E.ON | 83 |
HEIDELBERGER DRUCK | 80 |
REDCARE PHARMACY | 79 |